SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
FDA
Genentech’s Tecentriq Wins Second Approval of the Year, This Time for Lung Cancer
October 19, 2016
 · 
11 min read
Genentech Grows on Promise of 70+ Drug Approvals
Drug Development
Genentech’s Lung Cancer Drug Alecensa Gets 2nd FDA Breakthrough Status
October 4, 2016
 · 
2 min read
Genentech Grows on Promise of 70+ Drug Approvals
Business
Next in a String of Deals, Korea’s Hanmi Pharma Inks $910M Deal with Genentech
September 29, 2016
 · 
2 min read
Genentech Grows on Promise of 70+ Drug Approvals
Business
Genentech Gambles $310 Million+ on German Biotech BioNTech’s mRNA Cancer Vaccine Tech
September 21, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Cancer Drug Developed by Eliza Hall Institute, AbbVie and Genentech “Melts Away Cancer”
September 7, 2016
 · 
2 min read
Genentech Grows on Promise of 70+ Drug Approvals
Drug Development
Genentech’s Tecentriq Shows Positive Data in Phase III Trial, Has an Upcoming Action Date in October
September 1, 2016
 · 
3 min read
Meet 7 Bay Area Scientists Changing the Face of Biotech
Job Trends
Biotechs are Expanding in the Bay Area Again: Bristol-Myers Squibb, Genentech, Gilead, Illumina and Verily and More
August 26, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Led by Former Genentech Execs, Denali Banks $130 Million, Initiates Trial and Announces a Handful of Partnerships
August 25, 2016
 · 
3 min read
What a Day! Genentech Lands FDA Approval for First Drug to Treat Severe Multiple Sclerosis
Drug Development
Genentech Receives a Blow After Lymphoma Drug Flunks Phase III Test
July 18, 2016
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
FDA
Genentech Announces FDA Grants Venclexta (Venetoclax) Accelerated Approval For People With A Hard-To-Treat Type Of Chronic Lymphocytic Leukemia
April 12, 2016
 · 
11 min read
FDA
FDA Green Lights AbbVie, Genentech’s New Chronic Lymphocytic Leukemia Drug Venclexta
April 11, 2016
 · 
3 min read
Policy
FDA Accepts Genentech’s BLA and Grants Priority Review for Lung Cancer Drug Atezolizumab
April 11, 2016
 · 
4 min read
Business
SoCal’s Kite Pharma Grabs a Clinical Trial Cancer Deal with Genentech
March 17, 2016
 · 
1 min read
Policy
FDA Files Genentech’s Supplemental Biologics License Application Of Xolair (Omalizumab) For Pediatric Allergic Asthma
March 1, 2016
 · 
9 min read
Drug Development
Genentech Provides Update On Two Identical Phase Iii Studies Of Lebrikizumab In People With Severe Asthma
February 29, 2016
 · 
4 min read
FDA
FDA Green Lights Genentech’s Gazyva for Patients with Previously Treated Follicular Lymphoma
February 26, 2016
 · 
17 min read
Drug Development
FDA Grants Breakthrough Therapy Designation For Genentech’s Investigational Medicine Ocrelizumab In Primary Progressive Multiple Sclerosis
February 17, 2016
 · 
5 min read
Policy
Tennessee Oncology Sues Genentech Over Cancer Drug Herceptin
February 9, 2016
 · 
1 min read
Drug Development
Genentech Sponsored Study Reveals Hidden Stigma of Lung Cancer
January 21, 2016
 · 
3 min read
Load More